Skip to main content
OpenTrials

Clinical trial condition

Pneumonia, Viral

Explore clinical trials studying Pneumonia, Viral. Study availability and eligibility vary by location and protocol.

4,869 public trials 279 recruiting studies
Refine in advanced search Browse all conditions

Pneumonia, Viral trial results

Completed

Inhaled Heparin for Hospitalised COVID-19 Patients

NCT04635241

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • San Camilo Clinic Buenos Aires, Argentina
  • 15th May hospital Cairo, Egypt
  • RS Universitas Indonesia Depok, Indonesia
  • RSUP Dr Cipto Mangunkusumo Jakarta, Indonesia
View Trial Details
Completed

SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19

NCT05629962

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Atea Study Site Kingman, Arizona, United States
  • Atea Study Site Prescott, Arizona, United States
  • Atea Study Site Surprise, Arizona, United States
  • Atea Study Site Tucson, Arizona, United States
View all 263 locations
View Trial Details
Completed

National Project on Vaccines, COVID-19 and Frail Patients

NCT04848493

Conditions
COVID-19, Connective Tissue Diseases, Coronaviridae Infections, +18 more
Locations
  • IRCCS Istituto Tumori Giovanni Paolo II Bari, Italy
  • IRCCS Azienda Ospedaliera Universitaria Bologna, Bologhna, Italy
  • Ospedale Policlinico San Martino IRCCS Genova, Italy
  • Foindazione IRCCS Istituto Neurologico Carlo Besta Milan, Milano, Italy
View Trial Details
Completed

Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations

NCT06020118

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations
  • Valleywise Health Comprehensive Health Center Phoenix, Arizona, United States
  • ASU Biodesign Institute Tempe, Arizona, United States
  • Centers for Disease Control and Prevention Atlanta, Georgia, United States
  • Washington University IDCRU St Louis, Missouri, United States
View Trial Details
Completed

A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age

NCT04796896

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Children's of Alabama Birmingham, Alabama, United States
  • MedPharmics, LLC Phoenix, Arizona, United States
  • Emmaus Research Center Inc Anaheim, California, United States
  • Velocity Clinical Research - Banning - ERN- PPDS Banning, California, United States
View all 91 locations
View Trial Details

Related conditions